AbbVie Inc. - COM (ABBV)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
1.24B
Holdings value Q3 2024
$245B
Value change Q3 2024
-$3.97B
Grand Portfolio weight change Q3 2024
-0.008%
Number of holders
3409
Number of buys Q3 2024
1567
Number of sells Q3 2024
-1440
Average buys Q3 2024 %
+0.014%
Average sells Q3 2024 %
-0.054%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.24B $245B -$3.97B $197.48 3,428
2024 Q2 1.26B $216B +$5.8B $171.52 3,307
2024 Q1 1.23B $224B -$900M $182.10 3,307
2023 Q4 1.24B $192B +$5.4B $154.97 3,243
2023 Q3 1.2B $180B -$1.75B $149.06 3,050
2023 Q2 1.22B $164B -$1.67B $134.73 3,021
2023 Q1 1.23B $196B +$231M $159.37 3,091
2022 Q4 1.23B $198B +$2.58B $161.61 3,125
2022 Q3 1.22B $163B -$157M $134.21 2,927
2022 Q2 1.21B $186B +$3.47B $153.16 2,967
2022 Q1 1.2B $195B +$2.46B $162.11 3,020
2021 Q4 1.19B $161B +$1.03B $135.40 2,941
2021 Q3 1.17B $127B -$406M $107.87 2,630
2021 Q2 1.18B $133B -$658M $112.64 2,647
2021 Q1 1.18B $128B -$1.1B $108.22 2,586
2020 Q4 1.2B $128B -$1.07B $107.15 2,576
2020 Q3 1.21B $106B -$1.51B $87.59 2,353
2020 Q2 1.23B $120B +$14.4B $98.18 2,392
2020 Q1 1.08B $82.2B +$791M $76.19 2,212
2019 Q4 1.07B $94.4B +$1.22B $88.54 2,228
2019 Q3 1.06B $80B +$2.75B $75.72 2,004
2019 Q2 1.02B $74.1B +$135M $72.72 2,020
2019 Q1 1.03B $82.6B -$1.36B $80.59 2,025
2018 Q4 1.04B $96B -$2.27B $92.19 2,057
2018 Q3 1.06B $101B -$228M $94.58 1,952
2018 Q2 1.07B $98.8B -$4.62B $92.65 1,987
2018 Q1 1.12B $106B -$632M $94.65 2,008
2017 Q4 1.12B $109B +$376M $96.71 1,994
2017 Q3 1.12B $99.4B +$1.26B $88.86 1,787
2017 Q2 1.1B $79.9B +$1.07B $72.51 1,754
2017 Q1 1.1B $71.4B +$6.02B $65.16 1,719
2016 Q4 1.09B $68.3B -$1.52B $62.62 1,680
2016 Q3 1.11B $70.1B -$938M $63.07 1,635
2016 Q2 1.13B $69.7B +$1.28B $61.91 1,621
2016 Q1 1.11B $63.1B -$219M $57.12 1,623
2015 Q4 1.11B $66B -$1.79B $59.24 1,626
2015 Q3 1.14B $61.8B -$3.09B $54.41 1,591
2015 Q2 1.2B $80.5B +$5.99B $67.19 1,641
2015 Q1 1.11B $65.1B -$596M $58.54 1,589
2014 Q4 1.12B $73.4B -$8.36B $65.44 1,593
2014 Q3 1.25B $72.3B +$8.37B $57.76 1,491
2014 Q2 1.11B $62.7B +$2.58B $56.44 1,447
2014 Q1 1.07B $54.8B +$121M $51.40 1,413